The cellular phenotypes suggesting that ATM deficiency occurs in the AD models provides support for the concept that the altered chemistry of the AD brain produces, as one of its early consequences, a regionally variable loss of ATM function. This evidence concerns the gene ATM and Alzheimer disease.